Innate regeneration in the aging heart: Healing from within

Mayo Clinic Proceedings

Volumn 88, Issue 8, 2013, Pages 871-883

  Anversa, Piero ^a   Leri, Annarosa ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CARDIOMYOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL RENEWAL; CONFERENCE PAPER; HEALING; HEART INFARCTION; HEART MUSCLE; HEART REGENERATION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUSCLE CELL; NONHUMAN; SCAR; SENESCENCE; STEM CELL; TISSUE REGENERATION;

EID: 84884664680     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.04.001     Document Type: Conference Paper

References (127)

1. Anversa P, Leri A, Kajstura J. Cardiac regeneration. J Am Coll Cardiol. 2006;47(9): 1769-1776.
2. Murry CE, Field LJ, Menasché P. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112(20): 3174-3183.
3. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23(7): 845-856.
4. Rubart M, Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol. 2006;68: 29-49.
5. Hansson EM, Lindsay ME, Chien KR. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell. 2009;5(4): 364-377.
6. Yi BA, Wernet O, Chien KR. Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest. 2010;120(1): 20-28.
7. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A. 2003;100(18): 10440-10445.
8. Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A. 2005;102(24): 8692-8697.
9. Kajstura J, Gurusamy N, Ogórek B, et al. Myocyte turnover in the aging human heart. Circ Res. 2010;107(11): 1374-1386.
10. Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res. 2011;109(8): 941-961.
11. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest. 2013;123(1): 62-70.
12. Rota M, Hosoda T, De Angelis A, et al. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res. 2007;101(4): 387-399.
13. Bernhard D, Laufer G. The aging cardiomyocyte: a minireview. Gerontology. 2008;54(1): 24-31.
14. Shih H, Lee B, Lee RJ, Boyle AJ. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol. 2011;57(1): 9-17.
15. Maier B, Gluba W, Bernier B, et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004;18(3): 306-319.
16. Hosoda T, Rota M, Kajstura J, Leri A, Anversa P. Role of stem cells in cardiovascular biology. J Thromb Haemost. 2011; 9(suppl 1): 151-161.
17. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005;85(4): 1373-1416.
18. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81(4): 1161-1172.
19. Mori N, Horie Y, Nimura Y, Wolf R, Granger DN. Hepatic microvascular responses to ischemia-reperfusion in lowdensity lipoprotein receptor knockout mice. Am J Physiol Gastrointest Liver Physiol. 2000;279(6):G1257-G1264.
20. Mori A, Hashino S, Kobayashi S, et al. Avascular necrosis in the femoral head secondary to bone marrow infarction in a patient with graft-versus-host disease after unrelated bone marrow transplantation. Ann Hematol. 2001;80(4): 238-242.
21. Narayan S, Ezughah F, Standen GR, Pawade J, Kennedy CT. Idiopathic hypereosinophilic syndrome associated with cutaneous infarction and deep venous thrombosis. Br J Dermatol. 2003;148(4): 817-820.
22. Francque S, Condat B, Asselah T, et al. Multifactorial aetiology of hepatic infarction: a case report with literature review. Eur J Gastroenterol Hepatol. 2004;16(4): 411-415.
23. Leong FT, Freeman LJ. Acute renal infarction. J R Soc Med. 2005;98(3): 121-122.
24. Mackool RJ, Gittes GK, Longaker MT. Scarless healing: the fetal wound. Clin Plast Surg. 1998;25(3): 357-365.
25. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci. 2004;359(1445): 839-850.
26. Larson BJ, Longaker MT, Lorenz HP. Scarless fetal wound healing: a basic science review. Plast Reconstr Surg. 2010; 126(4): 1172-1180.
27. Leung A, Crombleholme TM, Keswani SG. Fetal wound healing: implications for minimal scar formation. Curr Opin Pediatr. 2012;24(3): 371-378.
28. Nye HL, Cameron JA, Chernoff EA, Stocum DL. Regeneration of the urodele limb: a review. Dev Dyn. 2003;226(2): 280-294.
29. Hata S, Namae M, Nishina H. Liver development and regeneration: from laboratory study to clinical therapy. Dev Growth Differ. 2007;49(2): 163-170.
30. Leri A, Kajstura J, Anversa P. Mechanisms of myocardial regeneration. Trends Cardiovasc Med. 2011;21(2): 52-58.
31. Kikuchi K, Holdway JE, Werdich AA, et al. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010;464(7288): 601-605.
32. Kikuchi K, Poss KD. Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol. 2012;28: 719-741.
33. Boni A, Urbanek K, Nascimbene A, et al. Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A. 2008; 105(40): 15529-15534.
34. Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011; 331(6020): 1078-1080.
35. Bailey B, Izarra A, Alvarez R, et al. Cardiac stem cell genetic engineering using the alphaMHC promoter. Regen Med. 2009;4(6): 823-833.
36. Hosoda T, Yasuzawa-Amano S, Amano K, et al. Defects in the c-kit-SCF system have profound effects on myocardial gene expression. Circulation. 2007;116:II-104.
37. Bastos Carvalho A, Carrillo-Infante C, D'Amario D, et al. Mutations of c-kit receptor are coupled with impaired growth and enhanced death of cardiac progenitor cells. Circulation. 2008;118:S-537-S-538.
38. Bailey B, Fransioli J, Gude NA, et al. Sca-1 knockout impairs myocardial and cardiac progenitor cell function. Circ Res. 2012;111(6): 750-760.
39. Kubin T, Pöling J, Kostin S, et al. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell. 2011;9(5): 420-432.
40. Leri A, Kajstura J, Anversa P. Cardiac regeneration and aging. In: Rosenthal N, Harvey RP, eds. Heart Development and Regeneration. Vol II. Waltham, MA: Academic Press; 2010: 951-980.
41. Leri A, Anversa P, Kajstura J. Stem cells and heart disease. In: Lanza R, Gearhart J, Hogan B, et al, eds. Essentials of Stem Cell Biology. 2nd ed. Waltham, MA: Academic Press; 2009: 529-542.
42. Sugimoto K, Gordon SP, Meyerowitz EM. Regeneration in plants and animals: dedifferentiation, transdifferentiation, or just differentiation? Trends Cell Biol. 2011;21(4): 212-218.
43. Kragl M, Roensch K, Nüsslein I, et al. Muscle and connective tissue progenitor populations show distinct Twist1 and Twist3 expression profiles during axolotl limb regeneration. Dev Biol. 2013;373(1): 196-204.
44. Gupta V, Poss KD. Clonally dominant cardiomyocytes direct heart morphogenesis. Nature. 2012;484(7395): 479-484.
45. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol. 2000;62: 289-319.
46. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998; 83(1): 1-14.
47. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 1998;83(1): 15-26.
48. Chien KR, Olson EN. Converging pathways and principles in heart development and disease: CV@CSH. Cell. 2002; 110(2): 153-162.
49. Oh H, Schneider MD. The emerging role of telomerase in cardiac muscle cell growth and survival. J Mol Cell Cardiol. 2002; 34(7): 717-724.
50. Chien KR, Karsenty G. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell. 2005;120(4): 533-544.
51. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344(23): 1750-1757.
52. Olivetti G, Ricci R, Anversa P. Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J Clin Invest. 1987; 80(6): 1818-1821.
53. Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res. 2003;93(7): 604-613.
54. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67(4): 871-885.
55. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004;94(4): 514-524.
56. Gonzalez A, Rota M, Nurzynska D, et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res. 2008;102(5): 597-606.
57. Murry CE, Lee RT. Development biology: turnover after the fallout. Science. 2009;324(5923): 47-48.
58. Parmacek MS, Epstein JA. Cardiomyocyte renewal. N Engl J Med. 2009;361(1): 86-88.
59. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829): 701-705.
60. Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A. 2007;104(45): 17783-17788.
61. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428(6983): 664-668.
62. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428(6983): 668-673.
63. Forester A. Handbuch der Speciellen Patholgischen Anatomie. Leipzig, Germany: 1852.
64. Zielonko G. Pathologisch anatomie und experiementelle studie uber hypertrophie des herzens. Virchows Arch Pathol Anat. 1875;62: 29-55.
65. Wideroe S. Histologische studien uber die muskulatur des herzens. Virchows Arch Pathol Anat. 1911;240: 190-196.
66. Aschoff L. Pathologische Anatomie. Leipzig, Germany: JA Barth; 1921.
67. Kaufmann E. Specielle Pathologische Anatomie. Berlin/Leipzig, Germany: 1922.
68. KarsnerHT, Saphir O, ToddTW. The state of the cardiac muscle in hypertrophy and atrophy. Am J Pathol. 1925;1(4): 351-372.
69. Petersen RO, Baserga R. Nucleic acid and protein synthesis in cardiac muscle of growing and adult mice. Exp Cell Res. 1965; 40(2): 340-352.
70. Morkin E, Ashford TP. MyocardialDNAsynthesis in experimental cardiac hypertrophy. Am J Physiol. 1968;215(6): 1409-1413.
71. Grove D, Nair KG, Zak R. Biochemical correlates of cardiac hypertrophy, 3: changes in DNA content; the relative contributions of polyploidy and mitotic activity. Circ Res. 1969;25(4): 463-471.
72. Grove D, Zak R, Nair KG, Aschenbrenner V. Biochemical correlates of cardiac hypertrophy, IV: observations on the cellular organization of growth during myocardial hypertrophy in the rat. Circ Res. 1969;25(4): 473-485.
73. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res. 1974;35(2, suppl II): 17-26.
74. Anversa P, Olivetti G. Cellular basis of physiologic and pathologic myocardial growth. In: Page E, Fozzard HA, Solaro RJ, eds. Handbook of Physiology. The Cardiovascular System, Section 2: The Heart. Vol 1. Bethesda, MD: American Physiological Society; 2001: 75-144.
75. Anversa P, Rota M, Urbanek K, et al. Myocardial aging: a stem cell problem. Basic Res Cardiol. 2005;100(6): 482-493.
76. Aurigemma GP. Diastolic heart failure: a common and lethal condition by any name. N Engl J Med. 2006;355(3): 308-310.
77. Kitzman DW, Gardin JM, Gottdiener JS, et al; Cardiovascular Health Study Research Group. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. Am J Cardiol. 2001;87(4): 413-419.
78. Aurigemma GP, Gaasch WH. Clinical practice: diastolic heart failure. N Engl J Med. 2004;351(11): 1097-1105.
79. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3): 260-269.
80. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355(3): 251-259.
81. Sanderson WC, Scherbov S. Average remaining lifetimes can increase as human populations age. Nature. 2005;435(7043): 811-813.
82. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statisticsd2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209.
83. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, part II: the aging heart in health: links to heart disease. Circulation. 2003;107(2): 346-354.
84. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107(3): 490-497.
85. Hadley EC, Lakatta EG, Morrison-Bogorad M, Warner HR, HodesRJ.The future of aging therapies. Cell. 2005;120(4): 557-567.
86. Kajstura J, Rota M, Cappetta D, et al. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012;126(15): 1869-1881.
87. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68(6): 1560-1568.
88. Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol. 1995; 26(4): 1068-1079.
89. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000;35(6): 1628-1637.
90. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6): 763-776.
91. Linke A, Müller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A. 2005;102(25): 8966-8971.
92. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007;104(35): 14068-14073.
93. Bearzi C, Leri A, Lo Monaco F, et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A. 2009;106(37): 15885-15890.
94. Hosoda T, D'Amario D, Cabral-Da-Silva MC, et al. Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A. 2009;106(40): 17169-17174.
95. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003; 100(21): 12313-12318.
96. Pfister O, Mouquet F, Jain M, et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res. 2005;97(1): 52-61.
97. Tomita Y, Matsumura K, Wakamatsu Y, et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol. 2005;170(7): 1135-1146.
98. Oyama T, Nagai T, Wada H, et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol. 2007;176(3): 329-341.
99. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7): 896-908.
100. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation. 2006; 113(11): 1451-1463.
101. Anversa P, Leri A, Rota M, et al. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells. 2007;25(3): 589-601.
102. Urbanek K, Cesselli D, Rota M, et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A. 2006;103(24): 9226-9231.
103. Hosoda T, Zheng H, Cabral-da-Silva M, et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation. 2011;123(12): 1287-1296.
104. Goichberg P, Bai Y, D'Amario D, et al. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circ Res. 2011;108(9): 1071-1083.
105. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev. 2008;88(2): 557-579.
106. Haigis MC, Yankner BA. The aging stress response. Mol Cell. 2010;40(2): 333-344.
107. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res. 2008;102(11): 1319-1330.
108. Blanpain C, Mohrin M, Sotiropoulou PA, Passegué E. DNAdamage response in tissue-specific and cancer stem cells. Cell Stem Cell. 2011;8(1): 16-29.
109. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130(2): 223-233.
110. Liu L, Rando TA. Manifestations and mechanisms of stem cell aging. J Cell Biol. 2011;193(2): 257-266.
111. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101(7): 1326-1342.
112. Leri A, Liu Y, Li B, et al. Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretchmediated apoptotic cell death. Am J Pathol. 2000;156(5): 1663-1672.
113. Leri A, Liu Y, Wang X, et al. Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res. 1999;84(7): 752-762.
114. Leri A, Liu Y, Claudio PP, et al. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Pathol. 1999;154(2): 567-580.
115. D'Amario D, Cabral-Da-Silva MC, Zheng H, et al. Insulinlike growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res. 2011;108(12): 1467-1481.
116. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A. 1994;91(21): 9857-9860.
117. Cesselli D, Beltrami AP, D'Aurizio F, et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol. 2011;179(1): 349-366.
118. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol. 2011;192(4): 547-556.
119. Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005; 97(7): 663-673.
120. Li Q, Ren J. Influence of cardiac-specific overexpression of insulin-like growth factor 1 on lifespan and aging-associated changes in cardiac intracellular Ca2+ homeostasis, protein damage and apoptotic protein expression. Aging Cell. 2007; 6(6): 799-806.
121. Agah R, Kirshenbaum LA, Abdellatif M, et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest. 1997;100(11): 2722-2728.
122. Martin K, Kirkwood TB, Potten CS. Age changes in stem cells of murine small intestinal crypts. Exp Cell Res. 1998;241(2): 316-323.
123. Rossi DJ, Bryder D, Zahn JM, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. 2005;102(26): 9194-9199.
124. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009;10(3): 207-217.
125. D'Amario D, Fiorini C, Campbell PM, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res. 2011;108(7): 857-861.
126. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378(9806): 1847-1857.
127. Chugh AR, Beache GM, Loughran JH, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012;126(11, suppl 1):S54-S64.